Logo
x

Search

Subscribe Now

Acute

BioXcel's BXCL501 Receives the US FDA's Breakthrough Therapy Designation for Acute Treatment of Agitation Associated with Dementia

BioXcel's BXCL501 Receives the US FDA's Breakthrough Therapy Designation for Acute Treatment of Agitation Associated with Dementia

  • March 15, 2021
Amgen Reports Results of Blincyto (blinatumomab) in P-III Study for Relapsed Acute Lymphoblastic Leukemia in Pediatric Patients

Amgen Reports Results of Blincyto (blinatumomab) in P-III Study for Relapsed Acute Lymphoblastic Leukemia in Pediatric Patients

  • March 3, 2021
Medtronic Launches Carpediem as the First Pediatric and Neonatal Acute Dialysis Machine in the US

Medtronic Launches Carpediem as the First Pediatric and Neonatal Acute Dialysis Machine in the US

  • December 9, 2020
FibroGen Report Enrollment of First Patient in P-II Study Evaluating Pamrevlumab in Patients Hospitalized with Acute COVID-19

FibroGen Report Enrollment of First Patient in P-II Study Evaluating Pamrevlumab in Patients Hospitalized with Acute COVID-19

  • June 24, 2020
Evoke's Gimoti (metoclopramide) Receives the US FDA's Approval to Relief Symptoms in Adults with Acute and Recurrent Diabetic Gastroparesis

Evoke's Gimoti (metoclopramide) Receives the US FDA's Approval to Relief Symptoms in Adults with Acute and Recurrent Diabetic Gast...

  • June 19, 2020
Dr. Reddy's Elyxyb (celecoxib oral solution) Receives the US FDA's Approval for Acute Treatment of Migraine with or Without Aura in Adults

Dr. Reddy's Elyxyb (celecoxib oral solution) Receives the US FDA's Approval for Acute Treatment of Migraine with or Without Aura i...

  • May 6, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.